Fluid Imaging Technologies Seeks Submissions for Research Grant - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fluid Imaging Technologies Seeks Submissions for Research Grant



Fluid Imaging Technologies announced a call for submissions for its Life Sciences & Materials Research Grant. Graduate students and senior undergraduates enrolled at a North American college or university who are studying biotechnology, biochemistry, material science/engineering, or related fields with an interest in micro-particle analysis are encouraged to apply for the use of a FlowCAM dynamic imaging particle analyzer to support their research.
 
The winner of the award will receive use of a FlowCAM for a period of up to four months, instrument training and on-going technical support, and a paid trip to an appropriate North American conference within 12 months of project completion to share the results of their work.  Judging criteria will include scientific merit, appropriate use of the FlowCAM, and the ability to obtain measurable results during a research period of four months. Proposals are due May 16, 2014.

Source:Fluid Imaging Technologies

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here